> AstraZeneca has submitted the first completely digital application to the FDA. The drug maker was able to rely on new technology--Signatures and Authentication for Everyone--to authentic the document in order to meet federal standards. The new process is expected to make it easier and less expensive to file with the FDA. Report
> Dyax announced that it has reached a mutual agreement with Genzyme Corporation to terminate their joint venture for the development and commercialization of DX-88 for hereditary angioedema. Release
> AstraZeneca's restructuring is claiming 700 jobs in Macclesfield in the UK. The pharma company also ruled out cuts in Japan. Report
> Bristol-Myers Squibb has closed on the purchase of 89 acres in Devens, MA and will begin construction of a 1.5 million square foot biologics manufacturing facility. Report
> Merck has stopped lobbying states to adopt its controversial HPV vaccine. Release
> IDM Pharma has raised $12.8 million in a private placement. Release
And Finally... Gene hunters are closing in on Lou Gehrig's disease. Report